The Medico Remedies IPO date has been confirmed from January 29, 2018 and ended on January 31, 2018.
Using an IPO, Medico Remedies is seeking to raise Rs 10.99 crores. Its price is ₹100 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹120,000.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
January 29-31
Price Range
₹100 per share
Face Value
₹10 per share
GMP
₹87.45
Medico Remedies IPO GMP
The Medico Remedies Limited IPO GMP is ₹87.45.
IPO Overview
The Medico Remedies initial public offering (IPO) has a set price of Rs 10.99 crores. Bidding for the Medico Remedies IPO began on January 29, 2018 and finished on January 31, 2018. On February 8, 2018, the shares were listed on the BSE SME. The Medico Remedies initial public offering (IPO) price is ₹100 per share. A minimum lot size of 1200 Shares is required for an application. Retail investors must make a minimum investment of ₹120,000 to participate.
They cater to formulation product wholesalers and traders. Uganda, Myanmar, Vietnam, Cambodia, Dominican Republic, Sri Lanka, Philippines, Turkmenistan, Ghana, Mauritius, Madagascar, Congo, Iraq, Honduras, Cuba, Jamaica, Hong Kong, Nigeria, Senegal, Panama, Mozambique, and other countries.
Medico Remedies IPO Details
IPO Date | January 29, 2018 to January 31, 2018 |
Listing Date | February 8, 2018 |
Face Value | ₹10 per share |
Price | ₹100 per share |
Lot Size | 1200 Shares |
Total Issue Size | 1,099,200 shares (aggregating up to ₹10.99 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
Market Maker portion | 57,600 shares |
Medico Remedies IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1200 | ₹120,000 |
Retail (Max) | 1 | 1200 | ₹120,000 |
Medico Remedies IPO Listing Details
Listing Date | February 8, 2018 |
BSE Script Code | 540937 |
NSE Symbol | MEDICO |
ISIN | INE630Y01016 |
Final Issue Price | ₹100 per share |
Company Profile
Medico Remedies Limited, founded in 1994, is a WHO-GMP & ISO-9001:2008 certified firm in India that manufactures and sells pharmaceutical formulation products. The company provides anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids, vitamins, haematinics, and other supplements, and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups, creams and gels.
Registrar Info
Name | Cameo Corporate Services Limited |
Phone number | +91-44-28460390 |
Email ID | — |
Website | ipo.cameoindia.com |
Contact Details
Name | Medico Remedies Ltd Contact Details |
Phone number | + 91-22-26701055/66 |
Email ID | info@medicoremedies.com |
Website | medicoremediesindia.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.